Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AVNS
stocks logo

AVNS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
174.70M
-2.73%
0.250
-41.86%
169.50M
+1.19%
0.230
-11.54%
175.90M
+0.51%
0.240
+41.18%
Estimates Revision
The market is revising No Change the revenue expectations for Avanos Medical, Inc. (AVNS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -12.50%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-12.50%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Avanos Medical Inc (AVNS.N) is 11.59, compared to its 5-year average forward P/E of 18.80. For a more detailed relative valuation and DCF analysis to assess Avanos Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
18.80
Current PE
11.59
Overvalued PE
27.39
Undervalued PE
10.21

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
9.96
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.88
Undervalued EV/EBITDA
4.04

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.59
Current PS
0.00
Overvalued PS
2.19
Undervalued PS
0.98
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

AVNS News & Events

Events Timeline

(ET)
2025-11-05
11:38:10
Avanos increases FY25 adjusted EPS forecast to 85c-95c, up from 75c-95c
select
2025-11-05
11:37:51
Avanos announces Q3 adjusted earnings per share of 22 cents, surpassing consensus estimate of 12 cents.
select
2025-10-23 (ET)
2025-10-23
08:03:23
Avanos to divest its US Game Ready orthopedic rental division to WRS Group
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-05PRnewswire
Avanos Medical, Inc. Announces Third Quarter 2025 Results

  • Financial Performance: Avanos Medical reported a 4.3% increase in net sales to $177.8 million for Q3 2025, but experienced a net loss of $1.4 million compared to a profit of $5.9 million in the same period last year.

  • Segment Growth: The Specialty Nutrition Systems segment achieved significant growth with net sales of $114.0 million, driven by strong demand in enteral feeding and neonate solutions, while the Pain Management & Recovery segment saw modest growth.

  • Acquisition and Guidance: The company completed the acquisition of Nexus Medical, enhancing its Specialty Nutrition Systems offerings, and raised its full-year revenue guidance to between $690 million and $700 million.

  • Challenges and Outlook: Avanos faces challenges from tariffs and a recent goodwill impairment charge of $77 million, but remains optimistic about mitigating these impacts through strategic measures.

[object Object]
Preview
9.5
10-27Newsfilter
Avanos Medical, Inc. to Host Webcast Conference Call on Third Quarter 2025 Financial Results

  • Conference Call Announcement: Avanos Medical, Inc. will host a conference call on November 5, 2025, at 9 a.m. ET to discuss its financial results and business highlights for the second quarter of 2025.

  • Accessing the Call: Participants can join the call via a registration link or by dialing specific phone numbers. A simultaneous webcast will also be available on the Avanos Medical website.

  • Company Overview: Avanos Medical is a medical technology company based in Alpharetta, Georgia, focused on providing innovative medical device solutions to improve patient care and reduce opioid use.

  • Additional Information: The company will release its financial results before the market opens on the same day as the conference call, and a replay of the call will be available for one week after the event.

[object Object]
Preview
4.5
10-24Yahoo Finance
Industry Update: Healthcare Sector

  • Health Care Stocks Performance: Health care stocks experienced a slight decline on Thursday, with the NYSE Health Care Index decreasing by 0.1%.

  • Market Overview: The overall market sentiment appears to be cautious, impacting the performance of health care stocks.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Avanos Medical Inc (AVNS) stock price today?

The current price of AVNS is 11.13 USD — it has decreased -1.59 % in the last trading day.

arrow icon

What is Avanos Medical Inc (AVNS)'s business?

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

arrow icon

What is the price predicton of AVNS Stock?

Wall Street analysts forecast AVNS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVNS is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Avanos Medical Inc (AVNS)'s revenue for the last quarter?

Avanos Medical Inc revenue for the last quarter amounts to 177.80M USD, increased 4.34 % YoY.

arrow icon

What is Avanos Medical Inc (AVNS)'s earnings per share (EPS) for the last quarter?

Avanos Medical Inc. EPS for the last quarter amounts to -0.03 USD, decreased -133.33 % YoY.

arrow icon

What changes have occurred in the market's expectations for Avanos Medical Inc (AVNS)'s fundamentals?

The market is revising No Change the revenue expectations for Avanos Medical, Inc. (AVNS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -12.50%.
arrow icon

How many employees does Avanos Medical Inc (AVNS). have?

Avanos Medical Inc (AVNS) has 2227 emplpoyees as of December 05 2025.

arrow icon

What is Avanos Medical Inc (AVNS) market cap?

Today AVNS has the market capitalization of 516.64M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free